Susquehanna Fundamental Investments, LLC Solid Biosciences Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $72,436 - $105,440	-42,862 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.38 - $3.77 $56,596 - $89,650	23,780 Added 124.62%	42,862 $102,000
Q2 2021 Aug 11, 2021	SELL	$3.49 - $5.51 $11,925 - $18,827	-3,417 Reduced 15.19%	19,082 $70,000
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $28,391 - $56,676	5,287 Added 30.72%	22,499 $124,000
Q4 2020 Feb 16, 2021	BUY	$3.08 - $7.79 $53,012 - $134,081	17,212 New	17,212 $130,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $43.7M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.